Pediatric endocrinology
Pediatric Diabetic Ketoacidosis
Pediatric diabetic ketoacidosis requires rapid confirmation of hyperglycemia, ketonemia, and acidosis; protocolized isotonic fluid resuscitation, potassium replacement, and delayed low-dose intravenous insulin; and intensive neurologic surveillance for cerebral edema while treating the precipitant and preventing recurrence.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
First decisions
Confirm DKA and identify patients needing higher-acuity care
Obtain treatment-critical studies without delaying resuscitation.
In a child or adolescent with diabetes symptoms, vomiting, abdominal pain, hyperventilation, dehydration, or altered consciousness, measure point-of-care glucose and blood β-hydroxybutyrate promptly. DKA requires hyperglycemia with plasma glucose >200 mg/dL, acidosis defined by pH <7.3 or bicarbonate <15 mmol/L, and β-hydroxybutyrate >3 mmol/L or urine ketones at least 2+.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE DKA can occur with normal glucose in patients already taking insulin; symptoms plus elevated ketones warrant urgent hospital assessment regardless of glucose.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
At diagnosis obtain glucose, blood ketones, pH and pCO2, bicarbonate, sodium, potassium, urea, creatinine, and body weight; document mental status, perfusion, vital signs, respiratory pattern, emesis, and clinical dehydration.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE Assess for infection or another precipitant when fever or hypothermia, hypotension, refractory acidosis, or lactic acidosis is present.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Classify severity as mild with pH <7.3 or bicarbonate <15 mmol/L, moderate with pH <7.2 or bicarbonate <10 mmol/L, and severe with pH <7.1 or bicarbonate <5 mmol/L.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Use one-to-one nursing in a high-dependency or pediatric ward setting for children <2 years or severe DKA; involve pediatric critical care for airway compromise, shock, or other critical illness.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Measure capillary glucose in children without known diabetes who have thirst, polyuria, weight loss, or fatigue plus nausea, vomiting, abdominal pain, hyperventilation, dehydration, or reduced consciousness.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
First hours
Use isotonic fluids, potassium, and continuous insulin in the correct sequence
Avoid insulin boluses and avoid stopping insulin solely because glucose has normalized.
For clinically dehydrated children without shock, give 0.9% sodium chloride 10 mL/kg intravenously over 30 minutes. Reassess perfusion before considering a second 10 mL/kg bolus and discuss additional boluses with the senior pediatric clinician. For hypotensive shock with a weak, thready pulse, give 10 mL/kg 0.9% sodium chloride promptly.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Calculate the first 48-hour fluid plan using estimated deficit plus maintenance. Assume 5% dehydration in mild-to-moderate DKA with pH ≥7.1 and 10% dehydration in severe DKA with pH <7.1; replace the deficit evenly over 48 hours. Use Holliday-Segar maintenance, capped at 75 kg, and subtract non-shock initial boluses from the estimated deficit.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Begin a soluble insulin infusion 1-2 hours after fluid therapy begins at 0.05-0.1 units/kg/hour; do not give an IV insulin bolus. Disconnect an insulin pump when IV insulin begins. If hypokalemia is present initially, provide potassium before starting insulin; if previously using basal insulin, continuing subcutaneous basal insulin can be considered in consultation with a diabetes specialist.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Use 0.9% sodium chloride without dextrose until plasma glucose is <252 mg/dL, then change to 0.9% sodium chloride with 5% dextrose and potassium chloride.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
When glucose is <108 mg/dL, increase the glucose concentration in IV fluid; if ketosis persists, continue insulin at least 0.05 units/kg/hour.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Do not administer IV sodium bicarbonate unless life-threatening hyperkalemia or severe acidosis has impaired cardiac contractility and pediatric critical care has been consulted.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Do not replace urinary losses with additional IV fluid during DKA therapy.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
| Step | Action | Operational detail |
|---|---|---|
| Assess airway, perfusion, neurologic status, and obtain diagnostic studies. | Use pediatric high-acuity care for severe DKA, age <2 years, shock, or impaired airway protection.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE |
| Give 0.9% sodium chloride. | 10 mL/kg over 30 minutes if dehydrated without shock; prompt 10 mL/kg for hypotensive shock.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE |
| Add potassium to ongoing fluids when appropriate. | Usually 40 mmol/L; replace before insulin if initial hypokalemia is present.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE |
| Begin continuous IV soluble insulin after fluids. | Start 1-2 hours after fluids at 0.05-0.1 units/kg/hour; no IV bolus.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE |
| Prevent hypoglycemia while continuing ketone clearance. | Add 5% dextrose when glucose is <252 mg/dL; increase dextrose if glucose is <108 mg/dL with persistent ketosis.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE |
Potassium and sodium management
Add potassium chloride 40 mmol/L to maintenance and rehydration fluids, excluding initial boluses, unless the patient is anuric or serum potassium is above the normal range. In patients initially hyperkalemic, add potassium once potassium is <5.5 mmol/L or urine output is documented. Insulin commonly unmasks total-body potassium depletion; do not delay replacement once it is safe.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Monitor sodium throughout therapy and calculate corrected sodium initially. Sodium should rise as glucose declines. A falling sodium concentration, or a rapid ongoing rise from free-water loss, may signal cerebral edema and requires immediate reassessment.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
If potassium falls below 3 mmol/L, consider temporarily suspending insulin and urgently discuss management with pediatric critical care; potassium concentrations >40 mmol/L require central venous access.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Safety surveillance
Monitor neurologic status, electrolytes, glucose, and ketone clearance
Cerebral edema is a clinical emergency, not an imaging diagnosis.
Record capillary glucose, vital signs, fluid input/output, and modified Glasgow Coma Scale at least hourly. In children <2 years and those with severe DKA, assess consciousness and heart rate every 30 minutes. Use continuous ECG monitoring during IV therapy to identify hypokalemia-associated abnormalities.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE Obtain laboratory glucose, pH/pCO2, sodium, potassium, urea, and β-hydroxybutyrate at 2 hours after treatment begins and at least every 4 hours thereafter.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
A physician should perform direct reassessment at diagnosis and at least every 4 hours, more frequently for severe DKA, age <2 years, or clinical concern. At each review, reassess neurologic status, vital signs, laboratory data, ECG, and cumulative fluid balance.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
If β-hydroxybutyrate is not declining by 6-8 hours, consider increasing insulin to 0.1 units/kg/hour or higher. Do not transition from IV to subcutaneous insulin until ketosis is resolving, the patient is alert, and oral fluids are tolerated without nausea or vomiting.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Early warning features of cerebral edema are headache, agitation or irritability, unexpected bradycardia, and increased blood pressure.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Treat immediately for cerebral edema with deterioration in consciousness, abnormal breathing or respiratory pauses, oculomotor palsy, or pupillary inequality/dilation.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Use either mannitol 20% 0.5-1 g/kg IV over 10-15 minutes or hypertonic sodium chloride 2.7% or 3%, 2.5-5 mL/kg IV over 10-15 minutes; seek immediate specialist guidance after treatment begins.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Transition to subcutaneous insulin at least 30 minutes before stopping IV insulin. For pump users, restart the pump at least 60 minutes before IV insulin cessation after changing the cartridge, infusion set, and subcutaneous site.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
After stabilization
Prevent recurrent DKA with structured sick-day care and barrier assessment
Recurrent DKA often reflects modifiable treatment, access, or psychosocial failure points.
Before discharge after DKA in established diabetes, review the likely precipitant directly with the child or adolescent and caregivers. Insulin omission, lack of uninterrupted insulin access, intercurrent illness, and psychosocial stressors are major recurrence risks.PubMed+1PubMedType 1 Diabetes in Children and Adolescents - PMC - NIHnice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE The diabetes team should provide individualized written sick-day instructions covering glucose and blood ketone monitoring, insulin adjustment, fluid and food intake, and thresholds for urgent contact or evaluation; revisit this plan at least annually.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Provide blood β-hydroxybutyrate strips and a meter, and advise ketone testing during illness or hyperglycemia. Blood ketone monitoring has practical advantages in young children and may identify metabolic deterioration earlier than urine testing.PubMedPubMedType 1 Diabetes in Children and Adolescents - PMC - NIH
Assess recurrent DKA for nonadherence sensitively and evaluate psychosocial well-being. Pediatric diabetes care should include access to multidisciplinary education, nutrition, mental health, and 24-hour clinical advice, with ongoing family involvement that is developmentally appropriate.PubMed+2PubMed14. Children and Adolescents: Standards of Care in Diabetes ...PubMedType 1 Diabetes in Children and Adolescents - PMC - NIHnice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Ensure an uninterrupted supply of basal and rapid-acting insulin; insulin omission is a leading cause of DKA.PubMedPubMedType 1 Diabetes in Children and Adolescents - PMC - NIH
Review injection or infusion sites and device troubleshooting, particularly for pump users because interrupted rapid-acting insulin delivery can rapidly produce ketosis.PubMedPubMedType 1 Diabetes in Children and Adolescents - PMC - NIH
Screen for depression, anxiety, diabetes distress, eating disorders, family conflict, food insecurity, and financial barriers when glycemic control is poor or DKA recurs.PubMed+1PubMed14. Children and Adolescents: Standards of Care in Diabetes ...PubMedType 1 Diabetes in Children and Adolescents - PMC - NIH
| Domain | Required action | Clinical purpose |
|---|---|---|
| Sick-day plan | Provide oral and written guidance on glucose and β-hydroxybutyrate monitoring, insulin adjustment, hydration, and escalation criteria. | Reduce delayed recognition of ketosis and recurrent DKA.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE |
| Ketone access | Supply a blood ketone meter and unexpired strips. | Enable illness and hyperglycemia assessment outside the hospital.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE |
| Insulin access | Verify access to uninterrupted insulin and delivery supplies. | Insulin omission or inability to obtain insulin increases DKA risk.PubMedPubMedType 1 Diabetes in Children and Adolescents - PMC - NIH |
| Psychosocial assessment | Address recurrent DKA, adherence barriers, distress, family conflict, and social needs. | Psychosocial factors can impair diabetes self-management.PubMed+1PubMed14. Children and Adolescents: Standards of Care in Diabetes ...PubMedType 1 Diabetes in Children and Adolescents - PMC - NIH |
Common questions
Can pediatric DKA occur with a normal glucose level?
Yes. Children and adolescents already receiving insulin may develop DKA with normal blood glucose. Nausea, vomiting, abdominal pain, hyperventilation, dehydration, or altered consciousness should trigger blood ketone measurement and urgent evaluation.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
Should an IV insulin bolus be given in pediatric DKA?
No. The cited pediatric DKA guideline recommends starting a continuous soluble insulin infusion 1-2 hours after IV fluids at 0.05-0.1 units/kg/hour and specifically advises against IV insulin boluses.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
When should dextrose be added during pediatric DKA treatment?
Change to 0.9% sodium chloride with 5% dextrose when plasma glucose falls below 14 mmol/L (252 mg/dL). If glucose falls below 6 mmol/L (108 mg/dL) with persistent ketosis, increase IV glucose while continuing insulin.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
What findings should trigger empiric treatment for cerebral edema?
Treat immediately when DKA is accompanied by declining consciousness, abnormal breathing, oculomotor palsy, or pupillary inequality or dilation. Headache, agitation, unexpected bradycardia, and hypertension are early warning signs requiring urgent assessment.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
When can intravenous insulin be stopped?
Do not stop IV insulin until ketosis is resolving, the patient is alert, and oral fluids are tolerated without nausea or vomiting. Give subcutaneous insulin at least 30 minutes before discontinuing IV insulin; restart a pump at least 60 minutes before stopping IV insulin.nice org uknice org ukRecommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE
References
- highlights of prescribing information — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use LEVEMIR® safely and effectively.See full prescribing information for LEVEMIR. LEVEMIR® (insulin detemir) injection, for subcutaneous useInitial U.S. Approval: 2005 — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- These highlights do not include all the information needed to use METFORMIN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for METFORMIN HYDROCHLORIDE TABLETS. METFORMIN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 1995 — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- rivaroxaban tablet, film coated XARELTO - DailyMed — dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
- Current Management of Type 1 Diabetes in Children: Guideline-based Expert Opinions and Recommendations — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Diabetes (type 1 and type 2) in children and young people: ... — www.nice.org.uk · www.nice.org.uk
- Management of Newly Diagnosed Type 2 Diabetes ... — pediatrics.aappublications.org · pediatrics.aappublications.org
- 14. Children and Adolescents: Standards of Care in Diabetes ... — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Type 1 Diabetes Mellitus | Pediatrics In Review — pedsinreview.aappublications.org · pedsinreview.aappublications.org
- Type 1 Diabetes in Children — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Type 1 Diabetes in Children and Adolescents - PMC - NIH — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Diabetes in Children and Adolescents - Diabetes in America - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Pediatric Type 2 Diabetes - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Pediatric Clinical Practice Guidelines & Policies — reader.aappublications.org · reader.aappublications.org
- Standards of Medical Care in Diabetes—2021 Abridged for ... — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Management of Type 2 Diabetes Mellitus in Children and ... — pediatrics.aappublications.org · pediatrics.aappublications.org
- 14. Children and Adolescents: Standards of Medical Care in ... — diabetesjournals.org · diabetesjournals.org
- Screening for Prediabetes and Type 2 Diabetes Mellitus in ... — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Prevention and Treatment of Type 2 Diabetes Mellitus in ... — pediatrics.aappublications.org · pediatrics.aappublications.org
- Diabetes Care - American Diabetes Association — diabetesjournals.org · diabetesjournals.org
- Recommendations | Diabetes (type 1 and type 2) in children and young people: diagnosis and management | Guidance | NICE — www.nice.org.uk · www.nice.org.uk
- Type 1 Diabetes Screening in Pediatrics — publications.aap.org · publications.aap.org
- Diabetes Clinical Practice Guideline Quick Reference Tools — publications.aap.org · publications.aap.org
- Management of Type 1 Diabetes in Children in the ... — publications.aap.org · publications.aap.org